Yutaka Yata

2.1k total citations
40 papers, 1.5k citations indexed

About

Yutaka Yata is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Yutaka Yata has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 12 papers in Epidemiology and 11 papers in Molecular Biology. Recurrent topics in Yutaka Yata's work include Liver physiology and pathology (12 papers), Liver Disease Diagnosis and Treatment (11 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Yutaka Yata is often cited by papers focused on Liver physiology and pathology (12 papers), Liver Disease Diagnosis and Treatment (11 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Yutaka Yata collaborates with scholars based in Japan, United States and China. Yutaka Yata's co-authors include Richard A. Rippe, Shimon Reif, David A. Brenner, Andrew Scanga, Toshiro Sugiyama, Erwin Gäbele, Takeshi Takahara, Kei Furui, Philip J. Gotwals and Kengo Kawai and has published in prestigious journals such as Journal of Biological Chemistry, Hepatology and Journal of Hepatology.

In The Last Decade

Yutaka Yata

37 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yutaka Yata Japan 16 755 640 453 325 176 40 1.5k
Birgit Lahme Germany 24 885 1.2× 641 1.0× 686 1.5× 260 0.8× 182 1.0× 35 1.6k
Jeffrey N. Lindquist United States 9 570 0.8× 555 0.9× 576 1.3× 193 0.6× 96 0.5× 12 1.5k
H Nakatsukasa Japan 23 796 1.1× 482 0.8× 567 1.3× 436 1.3× 335 1.9× 51 1.9k
Enis Kostallari United States 20 551 0.7× 649 1.0× 599 1.3× 213 0.7× 76 0.4× 33 1.4k
Karlin Raja Karlmark Germany 10 783 1.0× 896 1.4× 393 0.9× 253 0.8× 157 0.9× 13 1.8k
Kerstin Abshagen Germany 20 415 0.5× 383 0.6× 307 0.7× 305 0.9× 129 0.7× 46 1.1k
Mingyi Xu China 21 410 0.5× 511 0.8× 627 1.4× 163 0.5× 106 0.6× 56 1.3k
Harry Millward‐Sadler United Kingdom 12 962 1.3× 1.1k 1.7× 216 0.5× 525 1.6× 81 0.5× 14 1.6k
Sadataka Inuzuka Japan 16 524 0.7× 675 1.1× 263 0.6× 231 0.7× 78 0.4× 36 1.2k
Christer Baeck Germany 10 597 0.8× 763 1.2× 248 0.5× 171 0.5× 111 0.6× 11 1.4k

Countries citing papers authored by Yutaka Yata

Since Specialization
Citations

This map shows the geographic impact of Yutaka Yata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yutaka Yata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yutaka Yata more than expected).

Fields of papers citing papers by Yutaka Yata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yutaka Yata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yutaka Yata. The network helps show where Yutaka Yata may publish in the future.

Co-authorship network of co-authors of Yutaka Yata

This figure shows the co-authorship network connecting the top 25 collaborators of Yutaka Yata. A scholar is included among the top collaborators of Yutaka Yata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yutaka Yata. Yutaka Yata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hatanaka, Takeshi, Yutaka Yata, Naoto Saito, et al.. (2023). Relationship between Being Overweight and Clinical Outcomes of Ablation Therapy for Hepatocellular Carcinoma under Ultrasound Guidance: A Retrospective Analysis. Cancers. 15(4). 1289–1289. 3 indexed citations
2.
Hatanaka, Takeshi, Yutaka Yata, Atsushi Naganuma, & Satoru Kakizaki. (2023). Treatment Strategy for Intermediate-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization, Systemic Therapy, and Conversion Therapy. Cancers. 15(6). 1798–1798. 28 indexed citations
3.
Fukuda, Hiroki, Jiyoong Kim, Shin Ito, et al.. (2023). Metabolic syndrome is linked to the incidence of pancreatic cancer. EClinicalMedicine. 67. 102353–102353. 12 indexed citations
4.
Yata, Yutaka, Daisuke Kanda, Takeshi Hatanaka, et al.. (2012). Ruptured hepatocellular carcinoma successfully treated with systemic PEG-IFN and 5FU combination therapy: A case report. Kanzo. 53(8). 523–529.
5.
6.
Kanda, Daisuke, Hitoshi Takagi, Yutaka Yata, et al.. (2009). Novel Large-scale Deletion (whole Exon 7) in the ABCC2 Gene in a Patient with the Dubin-Johnson Syndrome. Drug Metabolism and Pharmacokinetics. 24(5). 464–468. 8 indexed citations
7.
Takahara, Takeshi, et al.. (2009). Lipopolysaccharide triggered TNF-α-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model. Journal of Hepatology. 51(1). 168–175. 136 indexed citations
8.
Kawai, Kengo, Yoshinari Atarashi, Terumi Takahara, et al.. (2009). Dietary supplement implicated in fulminant hepatic failure in a well-controlled Wilson disease patient. Clinical Journal of Gastroenterology. 2(2). 119–124. 2 indexed citations
9.
Takahara, Terumi, Feng Xue, Massimiliano Mazzone, et al.. (2008). Metron factor-1 prevents liver injury without promoting tumor growth and metastasis. Hepatology. 47(6). 2010–2025. 13 indexed citations
10.
Takahara, Terumi, Yutaka Yata, Feng Xue, et al.. (2007). Hepatocyte growth factor promotes colonic epithelial regeneration via Akt signaling. American Journal of Physiology-Gastrointestinal and Liver Physiology. 293(1). G230–G239. 25 indexed citations
11.
Atarashi, Yoshinari, Yukihiro Shimizu, Masaya Iwamoto, et al.. (2005). A domestic case of acute sporadic hepatitis E first identified in Toyama prefecture. Kanzo. 46(11). 647–652. 4 indexed citations
12.
Gäbele, Erwin, Shimon Reif, Shigeki Tsukada, et al.. (2005). The Role of p70S6K in Hepatic Stellate Cell Collagen Gene Expression and Cell Proliferation. Journal of Biological Chemistry. 280(14). 13374–13382. 78 indexed citations
13.
Li, Xiao‐Kang, Terumi Takahara, Yusuke Kitazawa, et al.. (2005). Human umbilical cord blood-derived cells differentiate into hepatocyte-like cells in the Fas-mediated liver injury model. American Journal of Physiology-Gastrointestinal and Liver Physiology. 289(6). G1091–G1099. 36 indexed citations
14.
Reif, Shimon, Alon Lang, Yutaka Yata, et al.. (2003). The Role of Focal Adhesion Kinase-Phosphatidylinositol 3-Kinase-Akt Signaling in Hepatic Stellate Cell Proliferation and Type I Collagen Expression. Journal of Biological Chemistry. 278(10). 8083–8090. 251 indexed citations
15.
Oka, Yoshitaka, Robert A. Waterland, J. Keith Killian, et al.. (2002). M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan. Hepatology. 35(5). 1153–1163. 52 indexed citations
16.
Yata, Yutaka, Philip J. Gotwals, Victor Koteliansky, & Don C. Rockey. (2002). Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-β soluble receptor: Implications for antifibrotic therapy. Hepatology. 35(5). 1022–1030. 140 indexed citations
17.
Yata, Yutaka, et al.. (1999). Expression of matrix metalloproteinase-13 and tissue inhibitor of metalloproteinase-1 in acute liver injury. Journal of Hepatology. 30(3). 419–424. 23 indexed citations
18.
Yata, Yutaka, Kazuhiko Okada, Shuji Nambu, et al.. (1998). CASE REPORT: Intrahepatic portal‐hepatic venous shunts associated with a huge pelvic leiomyoma. Journal of Gastroenterology and Hepatology. 13(2). 158–162. 6 indexed citations
19.
Takahara, Takeshi, Kei Furui, Yutaka Yata, et al.. (1997). Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human livers. Hepatology. 26(6). 1521–1529. 147 indexed citations
20.
Watanabe, Akiharu, et al.. (1995). Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability. Metabolic Brain Disease. 10(3). 239–248. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Birgit Lahme Breakdown of academic impact, for papers by Jeffrey N. Lindquist Breakdown of academic impact, for papers by H Nakatsukasa Breakdown of academic impact, for papers by Enis Kostallari Breakdown of academic impact, for papers by Karlin Raja Karlmark Breakdown of academic impact, for papers by Kerstin Abshagen Breakdown of academic impact, for papers by Mingyi Xu Breakdown of academic impact, for papers by Harry Millward‐Sadler Breakdown of academic impact, for papers by Sadataka Inuzuka Breakdown of academic impact, for papers by Christer Baeck
Rankless by CCL
2026